Hikma Expects Generics To Hit A High In 2021

Announces Finasteride License From Almirall As Latest In A Series Of Deals

 
• By David Wallace
  
High performance dial
Hikma is forecasting a generics profit margin at the high end of its guidance • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business